Wednesday, July 8, 2026

pharma · Osteoarthritis · Pain

Mundipharma

Mundipharma clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Sydney, AU HQ
1952 Founded
2,082 Employees
TGA registrant Type
Company details
Status
Public
HQ
Sydney, AU
Founded
1952
Employees
2,082
Programs
4
Drugs
23
Patents
0
Intelligence · Clinical Programs

Mundipharma projects

1 ClinicalTrials.gov programs sponsored by Mundipharma.

Mundipharma has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. CD101.IV.3.08

    Mundipharma Pty Limited

    Invasive Fungal Diseases in Adults undergoing Allogeneic Blood and Marrow Transplantation (BMT)

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Mundipharma have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.